- ICH GCP
- US Clinical Trials Registry
- Researchers
- France
- Leukemia, Myeloid, Acute
Medical specialists from France tagged as investigators in clinical trials studying Leukemia, Myeloid, Acute
Total 217 results
-
Raynier Devillier, MD,PhDSeen in:
- Bouches-du-Rhône, Marseille, Institut Paoli-Calmettes
Trials:- NCT03235973 (Principal Investigator)
Conditions: -
Regis CostelloSeen in:
- Marseille, Assistance Publique - Hopitaux de Marseille
- Marseille, CHU La Conception
- Marseille, Hoptial de la Conception APHM
- Marseille, Hôpital de la Conception
Trials:- NCT04797780 (Principal Investigator)
- NCT03801005 (Principal Investigator)
- NCT04603495 (Principal Investigator)
- NCT02489929 (Principal Investigator)
- NCT03337516 (Principal Investigator)
- NCT05260528 (Principal Investigator)
-
Richard Lemal, MDSeen in:
- Clermont-Ferrand, Chu Estaing
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Romain GuiezeSeen in:
- Clermont Ferrand, Chu Estaing
- Clermont-Ferrand, CHU Clermont-Ferrand
- Clermont-Ferrand, Chu Estaing
Trials:- NCT05246345 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT03439371 (Sub-Investigator)
-
Ronan TANGUYSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Safia ChebrekSeen in:
- Avignon, CH Avignon
Trials:- NCT05260528 (Principal Investigator)
Conditions: -
Samy ChraibiSeen in:
- Nîmes, Institut de Cancérologie du Gard
Trials:- NCT05260528 (Principal Investigator)
Conditions: -
Sandrine Loron, MDSeen in:
- Lyon, Centre Hospitalier Lyon Sud
Trials:- NCT03439371 (Sub-Investigator)
Conditions: -
Séverine RACADOTSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Sophie Ducastelle-Lepretre, MDSeen in:
- Lyon, Centre Hospitalier Lyon Sud
- Pierre-Bénite, Centre Hospitalier Lyon Sud, Hematology department
Trials:- NCT03796533 (Principal Investigator)
- NCT03439371 (Sub-Investigator)
Conditions: -
Sophie PARK, PrSeen in:
- Grenoble, CHU de Grenoble
- Grenoble, CHU de Grenoble/Clinique Universitaire d'hématologie 6e A
Trials:- NCT03503409 (Principal Investigator)
- NCT04827719 (Principal Investigator)
Conditions: -
Souad ASSAADSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
-
Souad ASSADSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04052126 (Sub-Investigator)
Conditions: -
Stanislas NIMUBONA, MDSeen in:
- Rennes, CHU Pontchaillou
- Rennes, Hôpital Pontchaillou
Trials:- NCT03223961 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05768711 (Principal Investigator)
-
Stéphane CHEZE, MDSeen in:
- Caen, CHU Côte de Nacre/Service d'Hématologie Clinique
- Caen, CHU de Caen
Trials:- NCT00411905 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT03223961 (Principal Investigator)
Conditions: -
Stephane De BottonSeen in:
- Villejuif, Institut Gustave Roussy
Trials:- NCT04797780 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT04067336 (Principal Investigator)
- NCT05260528 (Principal Investigator)
-
Stéphanie HaiatSeen in:
- Corbeil-Essonnes, Centre Hospitalier Sud Francilien (CHSF)
Trials:- NCT05260528 (Principal Investigator)
Conditions: -
Stéphanie Nguyen, MDSeen in:
- Paris, Hôpital de la Pitié-Salpêtrière
Trials:- NCT03439371 (Principal Investigator)
Conditions: -
Sylvain ChantepieSeen in:
- Caen, CHU de Caen
- Caen, Institut d'hématologie de Basse Normandie (IHBN)
Trials:- NCT05260528 (Principal Investigator)
- NCT03450512 (Principal Investigator)
Conditions: -
Sylvain Garciaz, Dr.Seen in:
- Marseille, Institute Paoli-Calmettes
Trials:- NCT04086264 (Principal Investigator)
Conditions: -
T. CluzeauSeen in:
- Nice, FR-Nice-LARCHET
Trials:- NCT04027309 (Principal Investigator)
-
Thomas BACHELOTSeen in:
- Lyon, Centre Leon Berard
Trials:- NCT04671693 (Sub-Investigator)
- NCT02029001 (Sub-Investigator)
-
Thomas CluzeauSeen in:
- Nice, Archet 1 Hospital
- Nice, CHU de Nice
- Nice, CHU de Nice - Hopital L'Archet
- Nice, CHU de Nice - Hôpital Archet 1
- Nice, CHU de Nice - Hôpital de l'Archet
- Nice, Hôpital Archet 1/Service d'Hématologie Clinique
- Nice, Hôpital l'Archet- CHU de Nice
Trials:- NCT04797780 (Principal Investigator)
- NCT04905407 (Principal Investigator)
- NCT03643042 (Principal Investigator)
- NCT05260528 (Principal Investigator)
- NCT01210274 (Principal Investigator)
- NCT03829072 (Principal Investigator)
- NCT03503409 (Principal Investigator)
- NCT03744390 (Principal Investigator)
- NCT04827719 (Principal Investigator)
- NCT05181735 (Principal Investigator)
- NCT06030089 (Principal Investigator)
-
Thorsten BraunSeen in:
- Bobigny, FR-Bobigny-AVICENNE
- Bobigny, Hôpital Avicenne
- Bobigny, Hôpital Avicenne APHP
Trials:- NCT04797780 (Principal Investigator)
- NCT04027309 (Principal Investigator)
- NCT05260528 (Principal Investigator)
-
Valérie Coiteux, MDSeen in:
- Lille, CHRU de Lille
Trials:- NCT03439371 (Sub-Investigator)
Conditions:
Clinical Trials on Leukemia, Myeloid, Acute
-
Massachusetts General HospitalExelixisCompletedRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
University of PennsylvaniaActive, not recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, Refractory | Acute Myeloid Leukemia, PediatricUnited States
-
Advesya SASNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryFrance, Sweden, Spain, Germany
-
Keystone Nano, IncMilton S. Hershey Medical Center; University of VirginiaNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia, RefractoryUnited States
-
Terrence J Bradley, MDImago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New...RecruitingAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Acute Myeloid Leukemia, in RelapseUnited States
-
National Cancer Institute (NCI)Active, not recruitingAcute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Adult Acute Monoblastic Leukemia | Adult Acute Monocytic Leukemia | Adult Acute Myeloid Leukemia With Maturation | Adult Acute Myeloid Leukemia Without Maturation | Adult Acute Myelomonocytic Leukemia | Alkylating Agent-Related Acute Myeloid... and other conditionsUnited States
-
Bhavana BhatnagarCTI BioPharmaCompletedRecurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Untreated Adult Acute Myeloid Leukemia | Therapy-Related Acute Myeloid LeukemiaUnited States
-
Washington University School of MedicineWithdrawnRefractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
C. Babis AndreadisGateway for Cancer Research; AVEO Pharmaceuticals, Inc.TerminatedAcute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Relapsed Acute Myeloid LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingAcute Myeloid Leukemia | Recurrent Adult Acute Myeloid Leukemia | Secondary Acute Myeloid Leukemia | Refractory Acute Myeloid LeukemiaUnited States